Carlos Ferrándiz

Prof. Dr. Carlos Ferrándiz

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 January 2021 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
CHC Hernández-Fernández
C Hernández-Fernández
GCG Carretero
G Carretero
RRR Rivera
R Rivera
CFCarlos Ferrándiz
Carlos Ferrándiz
EDEsteban Dauden
Esteban Dauden
AGa Group
a Group
The effect of gender on systemic therapy for psoriasis has not been well studied. The aim of this st...

27 September 2017 in International Journal of Cancer
Verified
Journal Article
Open access
PDF file
Aram BoadaAram Boada
Aram Boada
ATAntonio Tejera-Vaquerizo
Antonio Tejera-Vaquerizo
SRSimone Ribero
Simone Ribero
SPSusana Puig
Susana Puig
DMDavid Moreno-Ramírez
David Moreno-Ramírez
Eduardo NagoreEduardo Nagore
Eduardo Nagore
The clinical value of sentinel lymph node (SLN) biopsy in thick melanoma patients (Breslow >4 mm) has not been sufficiently studied. The aim of the study is to evaluate whether SLN biopsy increases survival in patients with thick cutaneous melanoma, and, as a secondary objective, to investigate correlations between survival and lymph node status. We included 1,211 consecutive patients with thick melanomas (>4 mm) registered in the participating hospitals' melanoma databases between 1997 and 2015. Median follow‐up was 40 months. Of these patients, 752 were matched into pairs by propensity scores based on sex, age, tumor location, histologic features of melanoma, year of diagnosis, hospital and adjuvant interferon therapy. The SLN biopsy vs. observation was associated with better DFS [adjusted hazard ratio (AHR), 0.74; 95% confidence interval (CI) 0.61–0.90); p = 0.002] and OS (AHR, 0.75; 95% CI, 0.60–0.94; p = 0.013) but not MSS (AHR, 0.84; 95% CI, 0.65–1.08; p = 0.165). SLN‐negative patients had better 5‐ and 10‐year MSS compared with SLN‐positive patients (65.4 vs. 51.9% and 48.3 vs. 38.8%; p = 0.01, respectively). As a conclusion, SLN biopsy was associated with better DFS but not MSS in thick melanoma patients after adjustment for classic prognostic factors. SLN biopsy is useful for stratifying these patients into different prognostic groups.

1 February 2020 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
Aram BoadaAram Boada
Aram Boada
ATAntonio Tejera-Vaquerizo
Antonio Tejera-Vaquerizo
SRSimone Ribero
Simone Ribero
SPSusana Puig
Susana Puig
DMDavid Moreno-Ramírez
David Moreno-Ramírez
MSMarina Sánchez-Lucas
Marina Sánchez-Lucas

15 December 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ATAntonio Tejera-Vaquerizo
Antonio Tejera-Vaquerizo
Aram BoadaAram Boada
Aram Boada
SRSimone Ribero
Simone Ribero
SPSusana Puig
Susana Puig
SPSabela Paradela
Sabela Paradela
Eduardo NagoreEduardo Nagore
Eduardo Nagore
The therapeutic value of sentinel lymph node biopsy (SLNB) in thin melanoma remains controversial. The aim of this study is to determine the role of SLNB in the survival of thin melanomas (≤1 mm). A multicenter retrospective observational study was designed. A propensity score matching was performed to compare patients who underwent SLNB vs. observation. A multivariate Cox regression was used. A total of 1438 patients were matched by propensity score. There were no significant differences in melanoma-specific survival (MSS) between the SLNB and observation groups. Predictors of MSS in the multivariate model were age, tumor thickness, ulceration, and interferon treatment. Results were similar for disease-free survival and overall survival. The 5- and 10-year MSS rates for SLN-negative and -positive patients were 98.5% vs. 77.3% (p < 0.001) and 97.3% vs. 68.7% (p < 0.001), respectively. SLNB does not improve MSS in patients with thin melanoma. It also had no impact on DSF or OS. However, a considerable difference in MSS, DFS, and OS between SLN-positive and -negative patients exists, confirming its value as a prognostic procedure and therefore we recommend discussing the option of SLNB with patients.

7 April 2020 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
Aram BoadaAram Boada
Aram Boada
ATAntonio Tejera-Vaquerizo
Antonio Tejera-Vaquerizo
SRSimone Ribero
Simone Ribero
SPSusana Puig
Susana Puig
DMDavid Moreno-Ramírez
David Moreno-Ramírez
SGSENTIMEL study group
SENTIMEL study group

1 October 2022 in Dermatology Practical & Conceptual
Verified
Journal Article
Open access
PDF file
NRNina Richarz
Nina Richarz
Aram BoadaAram Boada
Aram Boada
AJAne Jaka
Ane Jaka
JBJulio Bassas
Julio Bassas
CFCarlos Ferrándiz
Carlos Ferrándiz
OYOriol Yélamos
Oriol Yélamos
Citation: Richarz NA, Boada A, Jaka A, et al. UV Irradiation of Nevi: Impact on Performance of Electrical Impedance Spectroscopy and a Convolution Neural Network. Dermatol Pract Concept. 2022;12(4):e2022162. DOI: https://doi.org/10.5826/dpc.1204a162 Accepted: February 9, 2022; Published: October 2022 Copyright: ©2022 Richarz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Nina A. Richarz, MD, Department of Dermatology University Hospital Germans Trias i Pujol. Address: Carretera de Canyet s/n, 08916 Badalona, Barcelona, Spain. Phone: +34 934651200 E-mail: richarznina@gmail.com Introduction: In vivo reflectance confocal microscopy (RCM) is a useful tool for assessing pre-surgical skin tumor margins when performed by a skilled, experienced user. The technique, however, poses significant challenges to novice users, particularly when a handheld RCM (HRCM) device is used. Objective: To evaluate the performance of an HRCM device operated by a novice user to delineate basal cell carcinoma (BCC) margins before Mohs micrographic surgery (MMS) Methods: We performed a prospective study of 17 consecutive patients with a BCC in a high-risk facial area (the H zone) in whom tumor margins were assessed by HRCM and dermoscopy before MMS. Predicted surgical defect areas (cm2) were calculated using standardized photographic digital documentation and compared to final defect areas after staged excision. Results: No significant differences were observed between median HRCM-predicted and observed surgical defect areas (2.95 cm2 [range: 0.83–17.52] vs 2.52 cm2 [range 0.71–14.42]; p=0.586). Dermoscopy, by contrast, produced significantly underestimated values (median area of 1.34 cm2 [0.41-4.64] vs 2.52 cm2 [range 0.71-14.42]; p<0.001). Confounders leading to poor agreement between predicted and observed areas were previous treatment (n=5), a purely infiltrative subtype (n=1), and abundant sebaceous hyperplasia (n=1). Conclusion: Even in the hands of a novice user, HRCM is more accurate than dermoscopy for delineating lateral BCCs margins in high-risk areas and performs well at predicting final surgical defects. Keywords : reflectance confocal microscopy, basal cell carcinoma, micrographic Mohs surgery, margin control This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.